Lucid Diligence Brief: SELLAS REGAL AML Phase 3 Nears Final Analysis
Lucid Diligence Brief: SELLAS approaches REGAL AML final analysis for…
Vaccines Today—May 15, 2026
This weekly vaccines update covers early-stage clinical progress, immunotherapy…
Public Health Today—May 8, 2026
This weekly update in public health and biomedicine highlights emerging…
Vaccines Today—April 30, 2026
This weekly update in Vaccines Research highlights recent regulatory actions,…
Vaccines Today—April 24, 2026
This weekly update in vaccines and immunotherapy covers recent developments…
Public Health Today—March 20, 2026
This weekly public health update highlights recent developments across clinical…
Oncology Today—March 9, 2026
This week’s Oncology update highlights regulatory approvals, reimbursement…
Immunology Today—February 4, 2026
This weekly update in immunology covers significant developments in the field,…
Oncology Today—February 2, 2026
This weekly update in oncology covers regulatory actions, clinical progress,…
Vaccines Today—January 23, 2026
This week’s updates cover key advancements in clinical trials, regulatory…
Lucid Diligence Brief: Harbour BioMed and BMS collaboration on next-gen multi-specific antibodies
Lucid Diligence Brief: Harbour BioMed and BMS collaboration on next-gen…
